Glucotrack (GCTK) Total Non-Current Liabilities (2012 - 2025)
Glucotrack (GCTK) reported Total Non-Current Liabilities of $4.8 million for Q4 2025, up 216.28% year-on-year from $1.5 million in Q4 2024, and down 13.67% quarter-over-quarter from $5.5 million in Q3 2025.
Glucotrack (GCTK) has 14 years of Total Non-Current Liabilities data on file, last reported at $4.8 million in Q4 2025.
- For the quarter ending Q4 2025, Total Non-Current Liabilities rose 216.28% year-over-year to $4.8 million; the trailing twelve-month figure through Dec 2025 stood at $4.8 million (up 216.28% YoY), and the FY2025 full-year result was $4.8 million, up 216.28% from the prior year.
- Total Non-Current Liabilities for Q4 2025 stood at $4.8 million, down from $5.5 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $5.5 million in Q3 2025 and bottomed at $184000.0 in Q3 2023.
- A 5-year average of $1.6 million and a median of $235000.0 in 2021 frame the typical range for Total Non-Current Liabilities.
- Across the five-year window, Total Non-Current Liabilities tumbled 42.54% in 2021 and jumped 2514.67% in 2024, its largest moves.
- Tracing GCTK's Total Non-Current Liabilities over 5 years: stood at $227000.0 in 2021, then decreased by 14.1% to $195000.0 in 2022, then soared by 675.38% to $1.5 million in 2023, then dropped by 0.07% to $1.5 million in 2024, then surged by 216.28% to $4.8 million in 2025.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $4.8 million, $5.5 million, and $3.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 1.91 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 24.24 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 941.16 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 1.03 Bn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 8.65 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 3.78 Bn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 2.10 Bn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 12.54 Bn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 2.44 Bn |
| 10 | Glucotrack | 290,858.33 | -7.09 Mn | - | 4.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.78 Mn |
| Sep 30, 2025 | 5.54 Mn |
| Jun 30, 2025 | 3.33 Mn |
| Mar 31, 2025 | 2.18 Mn |
| Dec 31, 2024 | 1.51 Mn |
| Sep 30, 2024 | 4.81 Mn |
| Jun 30, 2024 | 3.71 Mn |
| Mar 31, 2024 | 1.54 Mn |
| Dec 31, 2023 | 1.51 Mn |
| Sep 30, 2023 | 184,000.00 |
| Jun 30, 2023 | 189,000.00 |
| Mar 31, 2023 | 193,000.00 |
| Dec 31, 2022 | 195,000.00 |
| Sep 30, 2022 | 191,000.00 |
| Jun 30, 2022 | 192,000.00 |
| Mar 31, 2022 | 212,000.00 |
| Dec 31, 2021 | 227,000.00 |
| Sep 30, 2021 | 234,000.00 |
| Jun 30, 2021 | 236,000.00 |
| Mar 31, 2021 | 231,000.00 |
| Dec 31, 2020 | 279,000.00 |
| Sep 30, 2020 | 207,637.00 |
| Jun 30, 2020 | 217,877.00 |
| Mar 31, 2020 | 402,018.00 |
| Dec 31, 2019 | 236,000.00 |
| Sep 30, 2019 | 396,235.00 |
| Jun 30, 2019 | 411,940.00 |
| Mar 31, 2019 | 429,399.00 |
| Dec 31, 2018 | 339,878.00 |
| Sep 30, 2018 | 1.22 Mn |
| Jun 30, 2018 | 1.14 Mn |
| Mar 31, 2018 | 1.18 Mn |
| Dec 31, 2017 | 1.14 Mn |
| Sep 30, 2017 | 1.13 Mn |
| Jun 30, 2017 | 1.13 Mn |
| Mar 31, 2017 | 1.11 Mn |
| Dec 31, 2016 | 1.02 Mn |
| Sep 30, 2016 | 1.18 Mn |
| Dec 31, 2015 | 656,146.00 |
| Sep 30, 2015 | 721,094.00 |
| Jun 30, 2015 | 776,923.00 |
| Mar 31, 2015 | 1.34 Mn |
| Dec 31, 2014 | 2.43 Mn |
| Jun 30, 2014 | 2.86 Mn |
| Mar 31, 2014 | 8.99 Mn |
| Dec 31, 2013 | 9.15 Mn |
| Sep 30, 2013 | 2.74 Mn |
| Jun 30, 2013 | 2.80 Mn |
| Mar 31, 2013 | 3.75 Mn |
| Dec 31, 2012 | 859,687.00 |